SCHEMBL5790135

SCHEMBL5790135

O=C1CN(S(=O)(=O)c2cc3ccc(Cl)cc3s2)CCN1Cc1cccc2cccnc12

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 20/20 0.60
F2 P00734 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5789485 0.89 F10 (0.62) F10F2
SCHEMBL1652818 0.84 F10 (0.68) F10F2
SCHEMBL1654478 0.81 F10 (0.75) F10F2
SCHEMBL1653109 0.81 F10 (0.80) F10F2
SCHEMBL1654339 0.81 F10 (0.73) F10F2
SCHEMBL1654599 0.79 F10 (0.68) F10F2
SCHEMBL1652422 0.79 F10 (0.68) F10F2
SCHEMBL1385904 0.79 F10 (0.62) F10F2
SCHEMBL1385156 0.78 F10 (0.59) F10F2
SCHEMBL1652743 0.78 F10 (0.67) F10F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1051176-B1 SUBSTITUTED OXOAZAHETEROCYCLYL FACTOR Xa INHIBITORS AVENTIS PHARMA INC (US) 2006-11-22 EP claimed